MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More! - Linda M. Richmond (Psychiatric News, 2026)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com